Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study

被引:96
作者
Ebrahimi-Fakhari, Daniel [1 ]
Mann, Lilian Lisa [1 ]
Poryo, Martin [2 ]
Graf, Norbert [3 ]
von Kries, Ruediger [4 ,5 ]
Heinrich, Beate [5 ]
Ebrahimi-Fakhari, Darius [6 ]
Flotats-Bastardas, Marina [1 ]
Gortner, Ludwig [1 ]
Zemlin, Michael [1 ]
Meyer, Sascha [1 ]
机构
[1] Saarland Univ, Med Ctr, Dept Pediat Neurol, Bldg 9,Kirrberger Str, D-66421 Homburg, Germany
[2] Saarland Univ, Med Ctr, Dept Pediat Cardiol, Homburg, Germany
[3] Saarland Univ, Med Ctr, Dept Pediat Oncol & Hematol, Homburg, Germany
[4] Ludwig Maximilians Univ Munchen, Inst Social Pediat & Adolescent Med, Div Epidemiol, Munich, Germany
[5] Heinrich Heine Univ, Coordinat Ctr Clin Studies, German Paediat Surveillance Unit ESPED, Dusseldorf, Germany
[6] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA
关键词
Epidemiology; Incidence; Tuberous sclerosis; Everolimus; mTOR; Prenatal rhabdomyoma; hamartomas; Neurologic manifestations; Infantile spasms; Seizures; COMPLEX CONSENSUS CONFERENCE; RETROSPECTIVE COHORT; PEDIATRIC-PATIENTS; DOUBLE-BLIND; PREVALENCE; EVEROLIMUS; CRITERIA; RECOMMENDATIONS; IDENTIFICATION; GENE;
D O I
10.1186/s13023-018-0870-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Tuberous Sclerosis Complex (TSC) is a rare multisystem disorder. In 2012 diagnostic criteria for TSC were revised. However, data on the incidence of TSC are limited. Methods: Prospective, national surveillance study in Germany over a 2-year-period (03/2015-02/2017) using current revised criteria for TSC. Patients up to the age of 18 years with a new diagnosis of definite or possible TSC (clinical and/or genetic) were included. The aims of this study were 1) to generate up-to-date data on the incidence of definite or possible TSC, 2) to assess age at first diagnosis, and 3) to compare these data with previous epidemiologic data. Results: In total, 86 patients met inclusion criteria (definite or possible TSC) with a median age at diagnosis of 6 months (range: 5 months before birth -197 months of age). Among patients identified with features of TSC, 73.3% met criteria for definite diagnosis (median age: 7 months) and 26.7% met criteria for a possible diagnosis (median age: 3 months). 55.8% of patients were male. When excluding prenatally diagnosed patients, median age at diagnosis was 11 months with a range of 0 to 197 months. The 3 most common clinical features at diagnosis of TSC were central nervous system involvement in 73.3% patients (of these 95.2% experienced seizures), cutaneous involvement in 58.1% patients (with the most common lesion being hypomelanotic macules in 92%) and cardiac rhabdomyoma in half of the patients. Cardiac rhabdomyoma were detected by prenatal ultrasonography in 22.1% of patients. The presence of cardiac rhabdomyoma was associated with cardiac arrhythmias in 25.6% (about 13% of all diagnosed patients) in our cohort. The overall prevalence of seizure disorders was 69.8%. The annual incidence rate of TSC is estimated at a minimum of 1:17.785 live births. However correcting for underreporting, the estimated incidence rate of definite or possible TSC is approximately 1:6.760-1:13.520 live births in Germany. Conclusions: This is the first study that assessed prospectively the incidence rate of TSC in children and adolescents using the updated diagnostic criteria of 2012. This prospective surveillance study demonstrates a low age at first diagnosis (median:6 months), likely due to antenatal detection of cardiac rhabdomyoma. Early diagnosis bears the potential for implementing effective therapies at an earlier stage.
引用
收藏
页数:8
相关论文
共 32 条
[1]  
[Anonymous], EUR J PAEDIAT NEUROL
[2]   Prospective clinical trials to investigate clinical and molecular biomarkers [J].
Auvin, Stehane ;
Walker, Lauren ;
Gallentine, William ;
Jozwiak, Sergiusz ;
Tombini, Mario ;
Sills, Graeme J. .
EPILEPSIA, 2017, 58 :20-26
[3]   Fetal rhabdomyoma: Prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex [J].
Bader, RS ;
Chitayat, D ;
Kelly, E ;
Ryan, G ;
Smallhorn, JF ;
Toi, A ;
Hornberger, UK .
JOURNAL OF PEDIATRICS, 2003, 143 (05) :620-624
[4]   Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial [J].
Bissler, John J. ;
Kingswood, J. Christopher ;
Radzikowska, Elzbieta ;
Zonnenberg, Bernard A. ;
Frost, Michael ;
Belousova, Elena ;
Sauter, Matthias ;
Nonomura, Norio ;
Brakemeier, Susanne ;
de Vries, Petrus J. ;
Whittemore, Vicky H. ;
Chen, David ;
Sahmoud, Tarek ;
Shah, Gaurav ;
Lincy, Jeremie ;
Lebwohl, David ;
Budde, Klemens .
LANCET, 2013, 381 (9869) :817-824
[5]   Molecular genetic advances in tuberous sclerosis [J].
Cheadle, JP ;
Reeve, MP ;
Sampson, JR ;
Kwiatkowski, DJ .
HUMAN GENETICS, 2000, 107 (02) :97-114
[6]   Tuberous sclerosis [J].
Curatolo, Paolo ;
Bombardieri, Roberta ;
Jozwiak, Sergiusz .
LANCET, 2008, 372 (9639) :657-668
[8]   Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants [J].
Davis, Peter E. ;
Filip-Dhima, Rajna ;
Sideridis, Georgios ;
Peters, Jurriaan M. ;
Au, Kit Sing ;
Northrup, Hope ;
Bebin, E. Martina ;
Wu, Joyce Y. ;
Krueger, Darcy ;
Sahin, Mustafa .
PEDIATRICS, 2017, 140 (06)
[9]   25 Years of ESPED as a Surveillance Tool for Rare Diseases in Children in Germany: A Critical Analysis [J].
Ebrahimi-Fakhari, Daniel ;
Zemlin, Michael ;
Sauer, Harald ;
Poryo, Martin ;
Graf, Norbert ;
Meyer, Sascha .
KLINISCHE PADIATRIE, 2018, 230 (04) :215-224
[10]   Dermatological manifestations of tuberous sclerosis complex (TSC) [J].
Ebrahimi-Fakhari, Daniel ;
Meyer, Sascha ;
Vogt, Thomas ;
Pfoehler, Claudia ;
Mueller, Cornelia Sigrid Lissi .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (07) :695-701